Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

128.63

-1.47 (-1.13%)

At close: Feb 20, 2026, 4:00 PM EST

128.76

+0.13 (0.10%)

After-hours: Feb 20, 2026, 6:19 PM EST

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	12,910	14,141	13,820	12,946	11,482	8,080
Market Cap Growth	-15.67%	2.32%	6.75%	12.75%	42.11%	-9.78%
Enterprise Value	11,901	13,506	12,878	12,124	10,966	7,766
Last Close Price	128.63	141.83	136.50	131.76	119.44	85.17
PE Ratio	27.54	29.55	40.49	51.85	74.32	90.18
Forward PE	16.19	15.87	18.15	21.34	22.53	24.55
PS Ratio	4.51	4.94	5.87	6.86	7.71	7.13
PB Ratio	3.96	4.35	5.34	5.80	6.72	5.88
P/TBV Ratio	3.97	4.35	5.34	5.91	6.90	5.88
P/FCF Ratio	17.24	18.89	24.80	35.80	35.56	34.66
P/OCF Ratio	16.49	18.07	23.21	33.20	33.83	31.50
PEG Ratio	0.82	0.75	0.31	0.65	0.66	0.37
EV/Sales Ratio	4.16	4.72	5.47	6.43	7.37	6.85
EV/EBITDA Ratio	17.85	20.26	20.64	29.14	41.44	35.51
EV/EBIT Ratio	18.70	21.22	21.57	30.71	44.04	37.38
EV/FCF Ratio	15.90	18.04	23.11	33.53	33.96	33.32
Debt / Equity Ratio	0.14	0.14	0.18	0.19	0.15	0.32
Debt / EBITDA Ratio	0.65	0.65	0.68	0.99	0.94	1.88
Debt / FCF Ratio	0.63	0.63	0.82	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.31	-0.31	-0.24	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.51	-1.51	-0.99	-1.45	-2.74	-1.24
Net Debt / FCF Ratio	-1.35	-1.35	-1.11	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	16.90	16.90	15.99	16.48	14.85	11.71
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	9.53%	9.53%	10.71%	8.78%	7.01%	6.82%
Return on Invested Capital (ROIC)	18.73%	20.50%	23.31%	22.75%	17.26%	19.95%
Return on Capital Employed (ROCE)	16.40%	16.40%	18.60%	15.20%	13.60%	11.40%
Earnings Yield	3.71%	3.38%	2.47%	1.93%	1.35%	1.11%
FCF Yield	5.80%	5.29%	4.03%	2.79%	2.81%	2.89%
Buyback Yield / Dilution	1.16%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%

Updated Feb 11, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q